[
    "{\"step_by_step_thinking\": \"The patient has elevated liver function tests and a positive HCV RNA, indicating active hepatitis C infection. The liver biopsy findings of mononuclear infiltrates limited to portal tracts and periportal hepatocyte necrosis are consistent with chronic hepatitis C. The most appropriate next step in management is antiviral therapy. The current standard of care for chronic hepatitis C is direct-acting antiviral (DAA) therapy. Sofosbuvir and ledipasvir are a combination of DAAs that are highly effective against HCV genotype 1, which is the genotype in this patient. Therefore, the most appropriate next step in management for this patient is A. Sofosbuvir and ledipasvir therapy.\", \"answer_choice\": \"A\"}"
]